The Court of Justice of the European Communities rejects the Commission’s appeal against the annulment of the rejection of exemption’s application (GlaxoSmithKline)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The general terms and conditions of sale applied by a drug manufacturer to its wholesalers implied, because of a differential pricing system, more onerous conditions when the products were intended for export. Since the agreement had the object of restricting parallel trade, the cartel infringement was initially

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Vogel & Vogel (Paris)
  • Vogel & Vogel (Paris)

Quotation

Louis Vogel, Joseph Vogel, The Court of Justice of the European Communities rejects the Commission’s appeal against the annulment of the rejection of exemption’s application (GlaxoSmithKline) , 3 September 2012, Concurrences N° 3-2009, Art. N° 52026, www.concurrences.com

Visites 294

All reviews